"Knowledge is what turns a terrifying diagnosis into a manageable one. We wrote this book so every man facing this, and everyone who loves him, has that from day one," said Kenny Kane, CEO of the ...

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

A new study co-led by WEHI has found a simple blood test can help identify the early-stage testicular cancer patients who are ...

In this study, researchers used the AHA’s PREVENT equation to evaluate cardiovascular disease risk in cisplatin-treated testicular cancer survivors.

Benjamin holds a Master's degree in anthropology from University College London and has previously worked in the fields of psychedelic neuroscience and mental health. Benjamin holds a Master's degree ...

A new study from scientists at the Cancer Center at Illinois provides important clues. The research shows that PFAS can directly interfere with how testicular cancer cells process fats and hormones, ...

Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates Testicular cancer is the most common malignancy in males age 15-40 years and ...

Testicular cancer is one of the most common cancers affecting young men, especially those between the ages of 20 and 40.

Study of late toxicities of chemotherapy regimens in testicular cancer survivors shows that higher cisplatin doses link renal impairment to increased heart health risks.